Qiagen N.V.
QGENNYSEHealthcare● Active
$36.69
+$0.01(+0.03%)
Market Cap$7.6B
P/E Ratio—
52W High$57.82
52W Low$32.53
Qiagen N.V. (QGEN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
QGEN · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$0.54
Est. $0.55 · -1.8%
Revenue
$0.49B
Est. $0.50B · -0.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▼ Miss EPS
QGEN reports quarterly as a NYSE-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $0.61 | — | — | — | $0.53B | — |
| ▼ Q2 FY2026 | May 6, 2026 | $0.55 | $0.54 | -1.8% | $0.49B | $0.50B | -0.8% |
| ▲ Q1 FY2026 | Feb 4, 2026 | $0.61 | $0.62 | +1.6% | $0.54B | $0.53B | +2.3% |
| ▲ Q4 FY2025 | Nov 4, 2025 | $0.61 | $0.64 | +4.9% | $0.53B | $0.53B | +1.3% |
| — Q3 FY2025 | Aug 5, 2025 | $0.60 | $0.60 | +0.0% | $0.53B | $0.52B | +3.5% |
| ▲ Q2 FY2025 | May 7, 2025 | $0.50 | $0.55 | +9.3% | $0.48B | $0.47B | +3.1% |
| ▲ Q1 FY2025 | Feb 5, 2025 | $0.60 | $0.61 | +1.7% | $0.52B | $0.52B | +0.5% |
| ▲ Q4 FY2024 | Nov 6, 2024 | $0.54 | $0.57 | +5.6% | $0.50B | $0.49B | +2.2% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$0.61
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Miss
EPS Actual
$0.54
EPS Est.
$0.55
EPS Surpr.
-1.8%
Revenue
$0.49B
Q1 FY2026
Feb 4, 2026Beat
EPS Actual
$0.62
EPS Est.
$0.61
EPS Surpr.
+1.6%
Revenue
$0.54B
Q4 FY2025
Nov 4, 2025Beat
EPS Actual
$0.64
EPS Est.
$0.61
EPS Surpr.
+4.9%
Revenue
$0.53B
Q3 FY2025
Aug 5, 2025
EPS Actual
$0.60
EPS Est.
$0.60
EPS Surpr.
+0.0%
Revenue
$0.53B
Q2 FY2025
May 7, 2025Beat
EPS Actual
$0.55
EPS Est.
$0.50
EPS Surpr.
+9.3%
Revenue
$0.48B
Q1 FY2025
Feb 5, 2025Beat
EPS Actual
$0.61
EPS Est.
$0.60
EPS Surpr.
+1.7%
Revenue
$0.52B
Q4 FY2024
Nov 6, 2024Beat
EPS Actual
$0.57
EPS Est.
$0.54
EPS Surpr.
+5.6%
Revenue
$0.50B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.73 | $0.74 | $0.75 | 3 |
| Q3 FY2028 | $0.71 | $0.72 | $0.74 | 3 |
| Q2 FY2028 | $0.68 | $0.69 | $0.71 | 3 |
| Q1 FY2028 | $0.63 | $0.64 | $0.65 | 3 |
| Q4 FY2027 | $0.70 | $0.71 | $0.72 | 2 |
| Q3 FY2027 | $0.68 | $0.69 | $0.70 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.6B | $0.6B | $0.6B | 2 |
| Q3 FY2028 | $0.6B | $0.6B | $0.6B | 2 |
| Q2 FY2028 | $0.6B | $0.6B | $0.6B | 2 |
| Q1 FY2028 | $0.5B | $0.5B | $0.5B | 2 |
| Q4 FY2027 | $0.6B | $0.6B | $0.6B | 3 |
| Q3 FY2027 | $0.6B | $0.6B | $0.6B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 6, 2026 | -1.8% | $34.00 | $34.44 | +1.29% |
| ▲ Q1 FY2026 | Feb 4, 2026 | +1.6% | $51.89 | $51.71 | -0.35% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +4.9% | $45.68 | $44.16 | -3.33% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +0.0% | $50.25 | $49.95 | -0.60% |
| ▲ Q2 FY2025 | May 7, 2025 | +9.3% | $42.17 | $42.63 | +1.09% |
| ▲ Q1 FY2025 | Feb 5, 2025 | +1.7% | $43.36 | $43.80 | +1.01% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +5.6% | $42.95 | $42.86 | -0.21% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +7.5% | $43.69 | $43.47 | -0.50% |
Q2 FY2026+1.29%
Report Date
May 6, 2026
EPS Beat/Miss
-1.8%
Price Before
$34.00
Price After
$34.44
Q1 FY2026-0.35%
Report Date
Feb 4, 2026
EPS Beat/Miss
+1.6%
Price Before
$51.89
Price After
$51.71
Q4 FY2025-3.33%
Report Date
Nov 4, 2025
EPS Beat/Miss
+4.9%
Price Before
$45.68
Price After
$44.16
Q3 FY2025-0.60%
Report Date
Aug 5, 2025
EPS Beat/Miss
+0.0%
Price Before
$50.25
Price After
$49.95
Q2 FY2025+1.09%
Report Date
May 7, 2025
EPS Beat/Miss
+9.3%
Price Before
$42.17
Price After
$42.63
Q1 FY2025+1.01%
Report Date
Feb 5, 2025
EPS Beat/Miss
+1.7%
Price Before
$43.36
Price After
$43.80
Q4 FY2024-0.21%
Report Date
Nov 6, 2024
EPS Beat/Miss
+5.6%
Price Before
$42.95
Price After
$42.86
Q3 FY2024-0.50%
Report Date
Jul 31, 2024
EPS Beat/Miss
+7.5%
Price Before
$43.69
Price After
$43.47
Avg Beat Reaction-0.41%
Avg Miss Reaction+1.29%
Beat Rate7 / 8 quarters
Largest Move-3.33% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: QGEN ends December
Qiagen N.V. (QGEN) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $0.54 — missing the analyst consensus of $0.55 by -1.8%. The next QGEN earnings date is expected around September 1, 2026.
Each quarter, investors track QGEN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. QGEN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
QGEN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
QGEN earnings · 5 questionsQiagen N.V.'s next earnings report is expected around September 1, 2026. QGEN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; QGEN historically reports after market close (AMC).
QGEN earnings datewhen is QGEN earningsQGEN next earnings datewhen does QGEN report earningsQGEN earnings calendar
▸ Source: FMP · Qiagen N.V. SEC filings · US GAAP · Qiagen N.V. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026